The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Frank L. Meyskens

Departments of Medicine

University of California

Irvine

USA

[email]@uci.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Departments of Medicine, University of California, Irvine, USA. 2011
  • Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California, USA. 1998 - 2009
  • UCI Cancer center Hematology/Oncology Bldg. 44, Route 81 101 city Drive cancer Center CA, USA. 2006

References

  1. Thinking about the role (largely ignored) of heavy metals in cancer prevention: hexavalent chromium and melanoma as a case in point. Meyskens, F.L., Yang, S. Recent Results Cancer Res. (2011) [Pubmed]
  2. Food extracts for chemoprevention: quo vadis?. Meyskens, F.L. Cancer. Prev. Res. (Phila. Pa) (2009) [Pubmed]
  3. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Meyskens, F.L., McLaren, C.E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P.M., Hawk, E., Kelloff, G., Lawson, M.J., Kidao, J., McCracken, J., Albers, C.G., Ahnen, D.J., Turgeon, D.K., Goldschmid, S., Lance, P., Hagedorn, C.H., Gillen, D.L., Gerner, E.W. Cancer. Prev. Res. (Phila) (2008) [Pubmed]
  4. UV or not UV: metals are the answer. Meyskens, F.L., Berwick, M. Cancer Epidemiol. Biomarkers Prev. (2008) [Pubmed]
  5. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development. Meyskens, F.L. Cancer Epidemiol. Biomarkers Prev. (2006) [Pubmed]
  6. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Meyskens, F.L., Szabo, E. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  7. Talking to a patient. Meyskens, F.L., Hietanen, P., Tannock, I.F. J. Clin. Oncol. (2005) [Pubmed]
  8. Principles of cancer prevention. Meyskens, F.L., Tully, P. Semin. Oncol. Nurs (2005) [Pubmed]
  9. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Meyskens, F.L., Farmer, P.J., Anton-Culver, H. Clin. Cancer Res. (2004) [Pubmed]
  10. Pulling the trigger. Meyskens, F.L., Fetting, J.H. J. Clin. Oncol. (2004) [Pubmed]
  11. Management of human melanoma: what has the last decade wrought?. Meyskens, F.L. Oncologist (2003) [Pubmed]
  12. Redox regulation in human melanocytes and melanoma. Meyskens, F.L., Farmer, P., Fruehauf, J.P. Pigment Cell Res. (2001) [Pubmed]
  13. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Meyskens, F.L., McNulty, S.E., Buckmeier, J.A., Tohidian, N.B., Spillane, T.J., Kahlon, R.S., Gonzalez, R.I. Free Radic. Biol. Med. (2001) [Pubmed]
  14. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer. Meyskens, F.L. Ann. N. Y. Acad. Sci. (2001) [Pubmed]
  15. Criteria for implementation of large and multiagent clinical chemoprevention trials. Meyskens, F.L. J. Cell. Biochem. Suppl. (2000) [Pubmed]
  16. Cancer population genetics and tumour prevention: an unfulfilled paradigm. Meyskens, F.L. Eur. J. Cancer (2000) [Pubmed]
  17. Cancer prevention in the year 2025: an anticipation. Meyskens, F.L. Eur. J. Cancer (2000) [Pubmed]
  18. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Meyskens, F.L., Gerner, E.W. Clin. Cancer Res. (1999) [Pubmed]
  19. Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Meyskens, F.L., Buckmeier, J.A., McNulty, S.E., Tohidian, N.B. Clin. Cancer Res. (1999) [Pubmed]
  20. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. Meyskens, F.L., Gerner, E.W., Emerson, S., Pelot, D., Durbin, T., Doyle, K., Lagerberg, W. J. Natl. Cancer Inst. (1998) [Pubmed]
 
WikiGenes - Universities